Epigenetic and genetic inactivation of tumor suppressor miR ‐135a in non‐small‐cell lung cancer

BACKGROUND: Despite therapeutic advances, lung cancer prognosis remains poor. Loss of heterozygosity (LOH) in the 3p21 region is well documented in lung cancer, but the specific causative genes have not been identified. MATERIALS AND METHODS: Here, we aimed to examine the clinical impact of miR‐135a...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin Eun, Jeon, Hyo Sung, Wee, Hyun Jung, Lee, Ji Yun, Lee, Won Kee, Lee, Shin Yup, Yoo, Seung Soo, Choi, Sun Ha, Kim, Dong Sun, Park, Jae Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101835/
https://www.ncbi.nlm.nih.gov/pubmed/36869643
http://dx.doi.org/10.1111/1759-7714.14838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101835/
https://www.ncbi.nlm.nih.gov/pubmed/36869643
http://dx.doi.org/10.1111/1759-7714.14838

Ejemplares similares